Skip to main navigation
  • Careers
  • Contact Us
  • About Us
    • Who We Are
    • Leadership
    • Careers
  • Collaborations
  • Our Science
    • DSTAT
    • Brincidofovir
    • ONC201
    • ONC206
    • ONC212
    • Our Pipeline
  • Patient Resources
    • Expanded Access
    • Our Programs
  • Investors
    • Press Releases
    • Presentations
    • Governance
    • Financials & Fillings
    • Stock Information
    • Investors FAQs
    • Request Information
  • Contact Us

Investors

FINANCIALS & FILINGS

Financial Menu

  • SEC Filings
  • Annual Reports and Proxies
  • Quarterly Results
Show all

2020

Fourth Quarter

  • Chimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational Update
  • Form 10-K

Proxy Statements

Date Filed View
Apr 28, 2020
0001117480-20-000018.pdf
0001117480-20-000018.rtf
0001117480-20-000018.xls
View HTML
Apr 29, 2019
0001117480-19-000019.pdf
0001117480-19-000019.rtf
0001117480-19-000019.xls
View HTML

Form 10-K

Date Filed View
Feb 25, 2021 View HTML
0001117480-21-000006.pdf
0001117480-21-000006.rtf
0001117480-21-000006.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 25, 2020 View HTML
0001117480-20-000006.pdf
0001117480-20-000006.rtf
0001117480-20-000006.xls
EX-101.INS - XBRL INSTANCE DOCUMENT

Form 10-Q

Date Filed View
Nov 5, 2020
0001117480-20-000032.pdf
0001117480-20-000032.rtf
0001117480-20-000032.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Aug 10, 2020
0001117480-20-000028.pdf
0001117480-20-000028.rtf
0001117480-20-000028.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Investor Relations

  • Investor Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Investor FAQs
  • Request Information

Shareholder Tools

  • Print
  • Email Alerts Subscription
  • RSS News Feeds
  • Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS


  • Privacy Policy
  • Terms & Conditions of Use
  • Forward-Looking Statements
  • Community Guidelines
  • References
  • Contact Us

© 2018 Chimerix. All rights reserved.

About Us
  • Who We Are
  • Leadership
  • Careers
Our Focus
  • Oncology
  • Biodefense
  • Collaborations
Our Science
  • DSTAT
  • Brincidofovir
  • Our Pipeline
Patient Resources
  • Expanded Access
Investors
  • Press Releases
  • Presentations
  • Governance
  • Financials & Filings
  • Stock Information
  • Investor FAQs
  • Request Information
Contact Us
  • Privacy Policy
  • Terms & Conditions of Use
  • Forward-Looking Statements
  • Community Guidelines
  • References
  • Contact Us

© 2018 Chimerix. All rights reserved.